Indeed, SMAD2 and SMAD4 are closely linked on chromosome 18q21, and therefore, in most breast tumors where one gene shows hemizygous loss, the other is also reduced to hemizygosity. This evidence concerns the gene SMAD4 and breast neoplasm.